Market Highlights
The global dry AMD market is expected to register a CAGR of 8.62% during the forecast period and hit USD 6,113.33 millionby 2027.
Age-related Macular Degeneration (AMD) is classified as either dry macular degeneration or wet macular degeneration. Neovascular macular degeneration may proceed to wet (neovascular) AMD, marked by blood vessels growing under the retina and leaking. Dry-type occurs more frequently, although it tends to go more slowly over the years. In general, moist-type tends to produce a change in vision that happens rapidly, culminating in severe vision loss.
Get Sample Report at https://www.marketresearchfuture.com/sample_request/10657
The growth of the dry AMD market worldwide is attributed to the growing geriatric population and increasing prevalence of age-related macular degeneration, and the introduction of novel treatment methods for dry AMD coupled with an increasing number of clinical trials focused on dry AMD. Other factors like increasing healthcare expenditure are likely to help the market grow. However, the high number of failed clinical trials for dry AMD drugs might hamper the market growth to some extent.
Key Players:
MRFR recognizes the following companies as the key players in the global dry AMD market—Santen Pharmaceuticals Inc. (Japan), Allergan plc (Ireland), Bausch Health (Canada), Alimera Science Inc. (US), Phio Pharmaceuticals Corp (US), Ocumension Therapeutics Co. Ltd (China), Belite Bio Inc. (US), Kubota Vision Inc. (US), Iveric Bio (US), Eyestem Research Pvt Ltd (India), Yuyang DNU Co., Ltd (South Korea), and Stealth Biotherapeutics Inc. (US).
Segment Analysis
The global macular degeneration treatment market has been divided based on stages, age group, route of administration, diagnosis& treatment, and end user.
The market, based on stages, has been segregated into early age-related macular degeneration, intermediate age-related macular degeneration, and late age-related macular degeneration.
Based on age group,the dry AMDmarket has been divided intoabove 75 years, above 60 years, and above 40 years.
Based on diagnosis & treatment, the dry AMD market has been divided into treatment and diagnosis.Treatment type is further bifurcated into nutrition therapy and telescopic lens implant. Nutrition therapy is again divided into antioxidants and others. Antioxidants arealso segregated as vitamins, zinc, copper, omega-3 fatty acids, and others.
Diagnosis is bifurcated into fluorescein angiogram, preliminary test, optical coherence tomography, and others.
Based on route of administration, the market is bifurcated into oral, intravitreal, and others.
On the basis of end user, the market is bifurcated into hospitals and clinics, diagnostic centers, academic research institutes, and others
Regional Analysis
The global dry AMD market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America dominated the global dry age-related macular degeneration market owing to the rising number of patients suffering from the condition. The increasing number of diabetic patients adds to the number of patients suffering from ophthalmologic conditions. The number of patients with retinal diseases such as dry AMD, retinal vein occlusion, and diabetic eye disease is steadily increasing in the US, according to a retrospective study presented during The Association for Research in Vision and Ophthalmology 2020.Europe holds the second largest market share due to the increasing older population and rising patient population. Additionally, improving government initiatives, increasing healthcare frames, and the rising demand for technologically innovative treatmentsaredriving the growth of the dry age-related macular degeneration market in Europe.The Asia-Pacific is the fastest-growing market for age-related macular degeneration as it is developing at a very rapid pace and has shown the emergence of many players. Moreover, the rising prevalence of eye disorders, increasing healthcare spending, and multinational companies moving towards the developing nations and setting operational set-ups are likely to drive the growth of the market. The Rest of the World is expected to witness a restricted growth due to limited access and healthcare affordability among the population. This region is segmented into Middle East, Africa, and Latin America. In the Middle East, the growth of the market is driven by increasing healthcare infrastructure and healthcare expenditure.
Access full report @ https://www.marketresearchfuture.com/reports/dry-age-related-macular-degeneration-amd-market-10657
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
